Benfotiamine

Description

Benfotiamine is a lipid-soluble derivative of vitamin B1. Benfotiamine overcomes the drawback of low bioavailability of water-soluble vitamin B1, increases the concentration of thiamine in blood and tissues, and thereby enhances the therapeutic effect.

Lyphar biotech supply Benfotiamine and many other supplement raw materials since 2011 with stable quality.Benfotiamine has been widely available in various countries around the world, including the United States, Japan, and Europe. Benfotiamine’s available forms include tablets, granules, and other types.

1. Diabetic neuropathy

Benfotiamine therapy appears to be a potential strategy for preventing diabetic nephropathy, a severe complication of diabetes, associated with a high risk of heart disease and mortality.

2. Cognitive improvement in Alzheimer’s disease

Preclinical studies have demonstrated that benfotiamine confers beneficial effects on cognitive impairment in Alzheimer’s disease. Benfotiamine has been shown to reduce amyloid deposition in animal models of Alzheimer’s disease.

3. Overcoming alcohol dependence

Chronic alcohol intake is associated with severe deficiency of vital nutrients and vitamins. Alcoholism-related thiamine deficiency are characterised by neurological syndromes due to progressive loss of central and peripheral white matter.

4. Benfotiamine for smoking

Smoking leads to endothelial dysfunction, an early event in cardiovascular disease. This is exacerbated by oxidative stress and inflammation.

5. Kidney protection

Data from studies in rat suggest that benfotiamine confers protective action to the peritoneal membrane and remnant kidney in peritoneal dialysis and uremia.